Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	262.79B
Revenue (ttm)	844.27B
Net Income (ttm)	8.75B
Shares Out	20.53M
EPS (ttm)	425.78
PE Ratio	30.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,983
Average Volume	18,973
Open	12,800
Previous Close	12,800
Day's Range	12,200 - 13,000
52-Week Range	10,600 - 13,550
Beta	0.55
RSI	74.05
Earnings Date	Jul 29, 2025

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 774
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2024, HOSE:DBT's revenue was 868.41 billion, an increase of 7.00% compared to the previous year's 811.62 billion. Earnings were 13.49 billion, an increase of 4.02%.